VitaBeads® Nano

Yttrium-stabilized zirconium oxide grinding beads (high-end quality) for pharmaceutical applications

General

General

VitaBeads® Nano produced from high- end yttria - stabilized zirconia powder, exhibits high crushing strenght, sphericity, surface quality and wear-resistance. These properties reduce contamination of pharmaceutial products during the grinding prozess to a minimum. VitaBeads® Nano possess a comprehensive documentation package. This allows our customers to make a quick and easy risk assessment.

VitaBeads Nano - Yttrium-stabilized zirconium oxide grinding beads (High-end quality) for pharmaceutical applications

Request information

Locations

Datos Técnicos

Datos Técnicos

TypeØ [mm]
VitaBeads® Nano 0.20.2
VitaBeads® Nano 0.30.3
VitaBeads® Nano 0.50.5
VitaBeads® Nano 0.80.8
VitaBeads® Nano 1.01.0

Chemical composition

about (in weight %)
ZrO2 + HfO295
Y2O35

Mechanical properties

Densitiy6.0 kg/l
Bulk density

3.6 kg/l

Young modulus> 200 GPa
Vickers hardness> 1200 HV
Aplicaciones

Aplicaciones

Ciencias de la vida

Videos

Videos
NETZSCH-Beads® english
Literatura

Literatura

Catálogo

Su petición

Su petición

Si quiere solicitar más información, por favor contacte con nuestro Dpto. Comercial , haciendo click en el botón.

También podría estar interesado en:

DeltaVita®

The comminution or desagglomeration of active pharmaceutical ingredients (API) is called micronization and brings about several advantages. The increase of the particle surface caused by the comminution results in a considerably better dissolution rate and bioavailability of the agents and therefore the APIs act faster.

NETZSCH DeltaVita® 15-300

The comminution or desagglomeration of active pharmaceutical ingredients (API) is called micronization and brings about several advantages. The increase of the particle surface caused by the comminution results in a considerably better dissolution rate and bioavailability of the agents and therefore the APIs act faster.

NETZSCH DeltaVita® 600

The comminution or desagglomeration of active pharmaceutical ingredients (API) is called micronization and brings about several advantages. The increase of the particle surface caused by the comminution results in a considerably better dissolution rate and bioavailability of the agents and therefore the APIs act faster.

We use cookies to personalize content and ads, provide social media features and analyze traffic to our website. By using this site you agree to the placement of cookies on your computer in accordance with the terms of our data protection policy.